Skip to main content

Innate Pharma (IPH.PA) Stock Price and Company Information, 2024

Innate Pharma

IPH.PA

Exchange: PA
Currency Euro
ISIN: FR0010331421
Primary Ticker: IPH.PA
Fiscal Year End: December
IPO Date: 2006-11-01
International Domestic: International
Sector: Healthcare
Industry: Biotechnology
Gic Sector: Health Care
Gic Group: Pharmaceuticals, Biotechnology & Life Sciences
Gic Industry: Biotechnology
Gic Sub Industry: Biotechnology
Description: Innate Pharma S.A., a biotechnology company, develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; IPH5201, a blocking antibody that is in Phase II clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; IPH6401, an BCMA-targeting NK cell engager; and IPH6101, a N Kp46-based NK cell engager that targets CD123 proprietary multi-specific antibody format; and IPH62, an B7-H3-targeting NK cell engager. Its products in preclinical trials are IPH43, an anti-MICA/B ADC and IPH45, an antibody drug conjugates (ADC); and IPH67, an undisclosed, multi-specific ANKET. The company has licensing and collaboration agreements with Astra Zeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with Med Immune Limited. Innate Pharma S.A. was incorporated in 1999 and is headquartered in Marseille, France.
Address: 117, Avenue de Luminy, Marseille, France, 13009
Code: IPHA
Exchange: US
Name: Innate Pharma
Website: https://www.innate-pharma.com
Full Time Employees: 168
Updated On: 2024-11-04

Highlights

Market Capitalization: 135349744
Market Capitalization Mln: 135.34
EBITDA: -35959000
Wall Street Target Price: 6.5
Book Value: 0.35
Earnings Share: -0.42
Most Recent Quarter: 2024-06-30
Profit Margin: -1.00
Operating Margin TTM: -2.13
Return On Assets TTM: -0.13
Return On Equity TTM: -0.78
Revenue TTM: 33788000
Revenue Per Share TTM: 0.41
Quarterly Revenue Growth YOY: -0.69
Gross Profit TTM: 57674000
Diluted Eps TTM: -0.42
Quarterly Earnings Growth YOY: -0.74

Valuation

Price Sales TTM: 4.00
Price Book MRQ: 4.78
Enterprise Value: 81482230
Enterprise Value Revenue: 3.27
Enterprise Value Ebitda: -9.78

Technicals

Beta: 0.78
52 Week High: 2.8
52 Week Low: 1.59
50 Day MA: 1.96
200 Day MA: 2.16

Earnings

Report Date: 2025-05-23
Date: 2025-03-31
Before After Market: Before Market
Currency: EUR
Report Date: 2024-11-13
Date: 2024-09-30
Currency: EUR
Report Date: 2024-09-12
Date: 2024-06-30
Before After Market: Before Market
Currency: EUR
Eps Estimate: -0.38
Eps Difference: 0.38
Surprise Percent: 10
Report Date: 2024-05-14
Date: 2024-03-31
Before After Market: Before Market
Currency: EUR
Report Date: 2024-03-21
Date: 2023-12-31
Before After Market: Before Market
Currency: EUR
Eps Estimate: -0.41
Eps Difference: 0.41
Surprise Percent: 10
Report Date: 2023-10-19
Date: 2023-09-30
Before After Market: After Market
Currency: EUR
Report Date: 2023-09-14
Date: 2023-06-30
Before After Market: Before Market
Currency: EUR
Eps Estimate: -0.14
Eps Difference: 0.14
Surprise Percent: 10
Report Date: 2023-05-09
Date: 2023-03-31
Before After Market: After Market
Currency: EUR
Report Date: 2023-03-23
Date: 2022-12-31
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.73
Eps Estimate: -0.32
Eps Difference: -0.41
Surprise Percent: -128.12
Report Date: 2022-11-14
Date: 2022-09-30
Before After Market: Before Market
Currency: EUR
Report Date: 2022-08-17
Date: 2022-06-30
Before After Market: After Market
Currency: EUR
Eps Actual: 0.08
Eps Estimate: -0.26
Eps Difference: 0.34
Surprise Percent: 130.76
Report Date: 2022-05-10
Date: 2022-03-31
Before After Market: Before Market
Currency: EUR
Report Date: 2022-03-24
Date: 2021-12-31
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.27
Eps Estimate: -0.32
Eps Difference: 0.05
Surprise Percent: 15.62
Report Date: 2021-10-26
Date: 2021-09-30
Before After Market: After Market
Currency: EUR
Report Date: 2021-08-30
Date: 2021-06-30
Before After Market: After Market
Currency: EUR
Eps Actual: -0.3
Eps Estimate: -0.23
Eps Difference: -0.07
Surprise Percent: -30.43
Report Date: 2021-05-11
Date: 2021-03-31
Before After Market: Before Market
Currency: EUR
Report Date: 2021-03-18
Date: 2020-12-31
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.68
Eps Estimate: -0.08
Eps Difference: -0.6
Surprise Percent: -75
Report Date: 2020-11-17
Date: 2020-09-30
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.08
Eps Estimate: -0.08
Report Date: 2020-09-08
Date: 2020-06-30
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.07
Eps Estimate: -0.37
Eps Difference: 0.3
Surprise Percent: 81.08
Report Date: 2020-05-12
Date: 2020-03-31
Before After Market: Before Market
Currency: EUR
Report Date: 2020-03-10
Date: 2019-12-31
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.16
Eps Estimate: -0.08
Eps Difference: -0.08
Surprise Percent: -10
Report Date: 2019-11-13
Date: 2019-09-30
Before After Market: Before Market
Currency: EUR
Eps Actual: 0.04
Eps Estimate: -0.08
Eps Difference: 0.12
Surprise Percent: 15
Report Date: 2019-09-13
Date: 2019-06-30
Before After Market: Before Market
Currency: EUR
Eps Actual: 0.2
Eps Estimate: 0.32
Eps Difference: -0.12
Surprise Percent: -37.
Report Date: 2019-05-15
Date: 2019-03-31
Before After Market: Before Market
Currency: EUR
Eps Estimate: 0.22
Eps Difference: -0.22
Surprise Percent: -10
Report Date: 2019-03-20
Date: 2018-12-31
Before After Market: Before Market
Currency: EUR
Eps Actual: 0.07
Eps Estimate: 0.07
Report Date: 2018-11-15
Date: 2018-09-30
Before After Market: Before Market
Currency: EUR
Eps Actual: 0.07
Eps Difference: 0.07
Report Date: 2018-09-14
Date: 2018-06-30
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.28
Eps Estimate: -0.64
Eps Difference: 0.36
Surprise Percent: 56.2
Report Date: 2018-05-16
Date: 2018-03-31
Before After Market: Before Market
Currency: EUR
Report Date: 2018-03-08
Date: 2017-12-31
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.46
Eps Estimate: -0.66
Eps Difference: 0.2
Surprise Percent: 30.30
Report Date: 2017-11-15
Date: 2017-09-30
Before After Market: Before Market
Currency: EUR
Report Date: 2017-09-18
Date: 2017-06-30
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.43
Eps Estimate: -0.27
Eps Difference: -0.16
Surprise Percent: -59.25
Report Date: 2017-05-15
Date: 2017-03-31
Before After Market: Before Market
Currency: EUR
Report Date: 2017-03-07
Date: 2016-12-31
Before After Market: Before Market
Currency: EUR
Eps Estimate: -0.42
Eps Difference: 0.42
Surprise Percent: 10
Report Date: 2015-02-19
Date: 2014-12-31
Before After Market: After Market
Currency: EUR
Eps Estimate: -0.1
Eps Difference: 0.1
Surprise Percent: 10
Report Date: 2014-09-17
Date: 2014-06-30
Before After Market: After Market
Currency: EUR
Eps Estimate: -0.19
Eps Difference: 0.19
Surprise Percent: 10
Report Date: 2014-02-11
Date: 2013-12-31
Currency: EUR
Eps Estimate: -0.06
Eps Difference: 0.06
Surprise Percent: 10
Date: 2014-12-31
Period: +1y
Revenue Estimate Avg: 7623000.00
Revenue Estimate High: 9300000.00
Revenue Estimate Number Of Analysts: 4.00
Revenue Estimate Growth: -0.54
Eps Trend7days Ago: -0.33
Eps Trend30days Ago: -0.33
Eps Trend60days Ago: -0.33
Eps Trend90days Ago: -0.33
Eps Revisions Down Last7days: 1.00
Eps Revisions Down Last30days: 1.00
Date: 2013-12-31
Revenue Estimate Avg: 16652000.00
Revenue Estimate High: 15320000.00
Revenue Estimate Number Of Analysts: 4.00
Revenue Estimate Growth: 0.16
Eps Trend7days Ago: -0.11
Eps Trend30days Ago: -0.11
Eps Trend60days Ago: -0.11
Eps Trend90days Ago: -0.11
Date: 2013-09-30
Period: +1q
Date: 2013-06-30
Revenue Estimate Low: 7000000.00
Revenue Estimate High: 7000000.00
Revenue Estimate Number Of Analysts: 1.00
Eps Trend7days Ago: -0.06
Eps Trend30days Ago: -0.06
Eps Trend60days Ago: -0.06
Eps Trend90days Ago: -0.06
Date: 2024-09-30
Date: 2023-12-31
Date: 2022-12-31
Eps Actual: -0.6
Date: 2021-12-31
Eps Actual: -0.5
Date: 2020-12-31
Eps Actual: -0.8
Date: 2019-12-31
Date: 2018-12-31
Eps Actual: -0.1
Date: 2017-12-31
Eps Actual: -0.8
Date: 2016-12-31
Date: 2014-12-31
Date: 2013-12-31